ChromoCure, Inc.
Limited financial coverage for KKUR.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
ChromoCure, Inc. specializes in designing and delivering exclusive systems for cancer identification. Their primary offering, the Chromosomal Scanner Series 200, is a detection system capable of identifying a distinct genomic characteristic that is universally present in all cancers yet entirely absent in healthy cells.
- IPO
- 2005
- Employees
- 4
- HQ
- Reno, US
Price Chart
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -10.90
- Avg Volume
- 3.74M
Get TickerSpark's AI analysis on KKUR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KKUR coverage
Recent articles, reports, and earnings notes.
No research on KKUR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KKUR report →Similar companies
Peers in the same neighborhood.